According to the latest market research study by Technavio, the global diabetic therapeutic market is expected to grow at a CAGR of close to 8% during the forecast period of 2017 to 2021.
This market research report by Technavio provides an in-depth analysis of the global diabetic therapeutic market regarding revenue and emerging market trends. The report also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.
Technavio research analysts categorize the market based on the type of disease
Click here to request a free sample of this report
The top three revenue contributing product segments are discussed below:
Global type 1 diabetes market: The global type 1 diabetes market is expected to grow at a rapid rate during the forecast period. Factors such as the increase in the global type 1 diabetic population and growing awareness are expected to contribute to this growth.
“The entry of biosimilars is also expected to support market growth. Merck is developing MK1293, whereas, Biocon is developing insulin glargine and Wockhardt is developing the insulin lispro. These are expected to be launched during the forecast period,” says Sapna Jha, a lead analyst at Technavio for research on cardiovascular and metabolic disorders.
Global type 2 diabetes market: The factors that are expected to influence the market positively are an increase in approvals of type 2 diabetes drugs by regulatory authorities and collaborations over type 2 diabetes management. The market is will also be affected by the increased market penetration of recently approved drugs, and an increase in the number of initiatives undertaken to understand physicians’ and individuals’ views and behavior regarding type 2 diabetes and its treatment.
Global gestational diabetes market: Gestational diabetes occurs during pregnancy in women when the glucose level in blood increases because of the body not being able to fulfill the additional demand of insulin production. As this type of diabetes usually ends with the pregnancy, the market share for this type of diabetes remains very low. The global gestational diabetes market is expected to grow at a moderate rate during the forecast period.
Ask an analyst to know more about this report
The top vendors operating in the global diabetic therapeutic market are:
- AstraZeneca
- Eli Lilly
- Merck
- Novo Nordisk
- Sanofi
The other prominent vendors in the market include AbbVie, Actelion Pharmaceuticals, Adocia, Aegerion Pharmaceuticals, Akros Pharma, Alnylam Pharmaceuticals, Amarin, Amgen, Amicus Therapeutics, Arbutus Biopharma, Arena Pharmaceuticals, Astellas Pharma, Atheronova, Aurobindo Pharma, Baxalta, Belrose Pharma, BHV Pharma, Biocon, Biodel, BioMarin, Bionaturis, Biosidus, Biospherics, Boehringer Ingelheim, Bristol-Myers Squibb, Catabasis Pharmaceuticals, Cerenis Therapeutics, Chipscreen Biosciences, Cipla, CJ HealthCare, CKD Bio, Concord Biotech, ConjuChem, CureDM, CymaBay Therapeutics, Daewoong, Daiichi Sankyo, Dance Biopharm, DiaMedica, Diamyd Therapeutics, Diasome Pharmaceuticals, DiaVacs, Dong-A ST, Eisai, Elcelyx Therapeutics, Esperion Therapeutics, Exsulin, F. Hoffmann-La Roche, Gan & Lee Pharmaceuticals, Generex Biotechnology, Genfit, GlaxoSmithKline, HanAll BioPharma, Hanmi Pharmaceutical, Hua Medicine, Iltoo Pharma, Intarcia Therapeutics, InteKrin Therapeutics, Intrexon, Ionis Pharmaceuticals, Islet Sciences, ISU Abxis, Janssen Pharmaceuticals, Japan Tobacco, JCR Pharmaceuticals, JW Pharmaceuticals, Kadmon Pharmaceuticals, Kamada, KinDex Pharmaceuticals, Kissei, Kotobuki, Kowa Company, Laboratoires SMB, Lexicon Pharmaceuticals, Ligand Pharmaceuticals, Living Cell Technologies, Livzon, LIXTE Biotechnology, Lupin, MacroGenics, Madrigal Pharmaceuticals, MannKind Corporation, MedImmune, Melior Pharmaceuticals, Merrion Pharmaceuticals, Merz Pharmaceuticals, Metabolic Solutions Development, Mitsubishi Tanabe Pharma, Mylan, Neothetics, Neuraltus Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Novartis, NuSirt Biopharma, Oramed, Orexigen Therapeutics, Osiris Therapeutics, Peptron, Perle Biosciences, Pfizer, PhaseBio Pharmaceuticals, Poxel, Protalix BioTherapeutics, Raptor, Recordati, Regeneron Pharmaceuticals, REGENX BioSciences, REGiMMUNE, Rhythm Pharmaceuticals, Saniona, Santaris Pharma, Sanwa Kagaku Kenkyusho, Serometrix, Shionogi, Shire, Sigma-Tau, Sirona Biochem, Strongbridge Biopharma, Sun Pharma, Takeda Pharmaceuticals, Teva, Thera Technologies, Theracos, Toleranzia, Tolerion, Torrent Pharmaceuticals, Transition Therapeutics, UCB, Utrecht Holdings, VeroScience, Vivus, vTv Therapeutics, XBiotech, Xeris Pharmaceuticals, XOMA, Zafgen, and Zydus Cadila.
A more detailed analysis is available in the Technavio report titled, ‘Global Diabetic Therapeutic Market 2017-2021’. Technavio also customizes reports by other regions and specific segments upon request.
Other related reports:
- Global Protein Therapeutics Market 2017-2021
- Global Diabetic Food Market 2016-2020
- Global Metabolic Disorders Therapeutics Market 2016-2020
To read more press releases – click here
